Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

Sac-TMT combined with Keytruda significantly improves progression-free survival in PD-L1-positive advanced non-small cell ...

In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association. In the US, ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes.

Lung cancer screening was associated with earlier-stage diagnoses and improved survival in a retrospective analysis of a large cohort with low screening uptake. Randomized trials have shown a ...

Significant progress is being made in the fight against lung cancer, according to a new study from the American Lung Association. But more work needs to be done. A state-by-state analysis says ...

The survival rate among those with lung cancer has improved by more than a quarter in the last five years, according to a new report. Four years ago, the United States Preventive Services Task Force ...

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

Nearly one in 10 American adults now report having been diagnosed with cancer at some point in their lives—a notable jump ...

LCMC Health is committed to reducing cancer rates throughout Louisiana. In recent months, the system has placed an emphasis ...